dipyridamole has been researched along with Cardiomyopathy, Hypertrophic Obstructive in 40 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
| Excerpt | Relevance | Reference |
|---|---|---|
| "1), with left ventricular hypertrophy, typical angina pectoris, ischemia that can be induced by exercise-electrocardiography test, without previous myocardial infarction, myocardial revascularization or diabetes mellitus, underwent dipyridamole-echocardiography test, thallium exercise myocardial scintigraphy and coronarography." | 9.08 | [Dipyridamole-echocardiography and thallium exercise myocardial scintigraphy in the diagnosis of obstructive coronary or microvascular disease in hypertensive patients with left ventricular hypertrophy and angina]. ( Astarita, C; Gambardella, S; Liguori, E; Maresca, FS; Nicolai, E; Rumolo, S, 1998) |
| "1), with left ventricular hypertrophy, typical angina pectoris, ischemia that can be induced by exercise-electrocardiography test, without previous myocardial infarction, myocardial revascularization or diabetes mellitus, underwent dipyridamole-echocardiography test, thallium exercise myocardial scintigraphy and coronarography." | 5.08 | [Dipyridamole-echocardiography and thallium exercise myocardial scintigraphy in the diagnosis of obstructive coronary or microvascular disease in hypertensive patients with left ventricular hypertrophy and angina]. ( Astarita, C; Gambardella, S; Liguori, E; Maresca, FS; Nicolai, E; Rumolo, S, 1998) |
| "Maximal wall thickness was identified as the strongest predictor of impaired dipyridamole-induced hyperemia and flow reserve in our study, whereas outflow tract obstruction was not an independent determinant." | 3.78 | PET/CT assessment of symptomatic individuals with obstructive and nonobstructive hypertrophic cardiomyopathy. ( Abraham, MR; Abraham, TP; Bengel, FM; Bravo, PE; Higuchi, T; Merrill, J; Pinheiro, A; Rischpler, C; Santaularia-Tomas, M; Wahl, RL, 2012) |
| "In 34 patients with HCM, PET was performed using (13)N-labeled ammonia during hyperemia induced by intravenous dipyridamole." | 3.74 | Spatial relationship between coronary microvascular dysfunction and delayed contrast enhancement in patients with hypertrophic cardiomyopathy. ( Betti, I; Camici, PG; Casolo, G; Cecchi, F; Olivotto, I; Pupi, A; Rega, L; Sciagrà, R; Sotgia, B, 2008) |
| "Twenty-nine patients (37%) showed ECG (ie, ST depression > or = 2 mV) signs of myocardial ischemia during dipyridamole test (group 1), whereas 50 (63%) had a negative test (group 2)." | 3.69 | Dipyridamole-induced ischemia as a prognostic marker of future adverse cardiac events in adult patients with hypertrophic cardiomyopathy. Echo Persantine Italian Cooperative (EPIC) Study Group, Subproject Hypertrophic Cardiomyopathy. ( Barilli, A; Ceriati, R; Iori, E; Lazzeroni, E; Maurizio, AR; Morozzi, L; Palma, G; Picano, E, 1997) |
| "Dipyridamole MBF was 1." | 2.69 | Transmural myocardial blood flow distribution in hypertrophic cardiomyopathy and effect of treatment. ( Boyd, H; Camici, PG; Choudhury, L; Elliott, P; Lammertsma, AA; McKenna, WJ; Rimoldi, O; Ryan, M, 1999) |
| "Verapamil has been shown to ameliorate silent myocardial perfusion defects documented by thallium-201 in patients with HC." | 2.67 | Effect of verapamil on absolute myocardial blood flow in hypertrophic cardiomyopathy. ( Camici, PG; Cecchi, F; Choudhury, L; Gistri, R; Montereggi, A; Salvadori, PA; Sorace, O, 1994) |
| "For the secondary left ventricular hypertrophy patient group, baseline myocardial blood flow was 1." | 1.30 | Coronary vasodilator reserve in primary and secondary left ventricular hypertrophy. A study with positron emission tomography. ( Camici, PG; Choudhury, L; Nihoyannopoulos, P; Patel, D; Rosen, SD, 1997) |
| "Fourteen patients with chronic renal failure (CRF) were studied by dipyridamole 201Tl myocardial scintigraphy." | 1.29 | [Study of washout rate in patients with chronic renal failure by dipyridamole 201Tl myocardial scintigraphy--comparison with hypertrophic cardiomyopathy]. ( Ito, T; Matsumura, K; Mizutani, Y; Nakagawa, T; Senda, Y; Takagi, I; Yasuda, R; Yoshida, N, 1993) |
| "Dipyridamole-assessed CFR, was weakly related to parameters of exercise capacity." | 1.29 | Coronary flow reserve and exercise capacity in hypertrophic cardiomyopathy. ( Bodzoń, W; Dimitrow, PP; Dubiel, JS; Krzanowski, M; Szczeklik, A, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (22.50) | 18.7374 |
| 1990's | 21 (52.50) | 18.2507 |
| 2000's | 7 (17.50) | 29.6817 |
| 2010's | 3 (7.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Castagnoli, H | 1 |
| Ferrantini, C | 1 |
| Coppini, R | 1 |
| Passeri, A | 1 |
| Baldini, K | 1 |
| Berti, V | 1 |
| Cecchi, F | 4 |
| Olivotto, I | 3 |
| Sciagrà, R | 2 |
| Sotgia, B | 1 |
| Casolo, G | 1 |
| Rega, L | 1 |
| Betti, I | 1 |
| Pupi, A | 1 |
| Camici, PG | 6 |
| Cortigiani, L | 1 |
| Rigo, F | 1 |
| Gherardi, S | 1 |
| Galderisi, M | 1 |
| Sicari, R | 1 |
| Picano, E | 5 |
| Bravo, PE | 2 |
| Pinheiro, A | 2 |
| Higuchi, T | 1 |
| Rischpler, C | 1 |
| Merrill, J | 2 |
| Santaularia-Tomas, M | 1 |
| Abraham, MR | 2 |
| Wahl, RL | 2 |
| Abraham, TP | 2 |
| Bengel, FM | 2 |
| Pozios, I | 1 |
| Tsui, BM | 1 |
| Cannon, RO | 2 |
| Gistri, R | 5 |
| Lorenzoni, R | 3 |
| Chiriatti, G | 4 |
| Lazzeroni, E | 2 |
| Dodi, C | 1 |
| Morozzi, L | 2 |
| Chiriatti, GP | 1 |
| Lu, C | 1 |
| Botti, G | 1 |
| Choudhury, L | 3 |
| Montereggi, A | 1 |
| Sorace, O | 1 |
| Salvadori, PA | 2 |
| Pedrinelli, R | 1 |
| Spessot, M | 1 |
| Salvadori, P | 2 |
| Catapano, G | 1 |
| Panarace, G | 1 |
| Papi, L | 3 |
| L'Abbate, A | 3 |
| Matsumura, K | 1 |
| Senda, Y | 1 |
| Ito, T | 1 |
| Mizutani, Y | 1 |
| Yoshida, N | 1 |
| Yasuda, R | 1 |
| Takagi, I | 1 |
| Nakagawa, T | 1 |
| Takata, J | 1 |
| Counihan, PJ | 1 |
| Gane, JN | 2 |
| Doi, Y | 3 |
| Chikamori, T | 1 |
| Ozawa, T | 2 |
| McKenna, WJ | 4 |
| Taki, J | 1 |
| Nakajima, K | 1 |
| Bunko, H | 1 |
| Shimizu, M | 1 |
| Taniguchi, M | 1 |
| Hisada, K | 1 |
| Motz, W | 1 |
| Strauer, BE | 1 |
| Elliott, PM | 2 |
| Rosano, GM | 1 |
| Gill, JS | 1 |
| Poole-Wilson, PA | 1 |
| Kaski, JC | 2 |
| Dimitrow, PP | 1 |
| Krzanowski, M | 1 |
| Bodzoń, W | 1 |
| Szczeklik, A | 1 |
| Dubiel, JS | 1 |
| Rosen, SD | 1 |
| Patel, D | 1 |
| Nihoyannopoulos, P | 1 |
| Maurizio, AR | 1 |
| Palma, G | 1 |
| Ceriati, R | 1 |
| Iori, E | 1 |
| Barilli, A | 1 |
| Yamada, M | 2 |
| Prasad, K | 1 |
| Lowe, CM | 1 |
| Kalsi, KK | 1 |
| Smolenski, RT | 1 |
| Pritchard, RD | 1 |
| Khaghani, A | 1 |
| Seymour, AM | 1 |
| Yacoub, MH | 1 |
| Astarita, C | 1 |
| Nicolai, E | 1 |
| Liguori, E | 1 |
| Gambardella, S | 1 |
| Rumolo, S | 1 |
| Maresca, FS | 1 |
| Elliott, P | 1 |
| Rimoldi, O | 1 |
| Ryan, M | 1 |
| Lammertsma, AA | 1 |
| Boyd, H | 1 |
| Kawada, N | 1 |
| Sakuma, H | 1 |
| Yamakado, T | 1 |
| Takeda, K | 1 |
| Isaka, N | 1 |
| Nakano, T | 1 |
| Higgins, CB | 1 |
| Tadamura, E | 1 |
| Yoshibayashi, M | 1 |
| Yonemura, T | 1 |
| Kudoh, T | 1 |
| Kubo, S | 1 |
| Motooka, M | 1 |
| Nohara, R | 1 |
| Matsumori, A | 1 |
| Sasayama, S | 1 |
| Matsuda, T | 1 |
| Tamaki, N | 1 |
| Konishi, J | 1 |
| Pingitore, A | 1 |
| Paterni, M | 1 |
| Passera, M | 1 |
| Paeng, JC | 1 |
| Lee, DS | 1 |
| Yeo, JS | 1 |
| Noh, CI | 1 |
| Kim, YK | 1 |
| Chung, JK | 1 |
| Lee, MC | 1 |
| Koga, Y | 2 |
| Kihara, K | 3 |
| Yamaguchi, R | 3 |
| Wada, T | 1 |
| Toshima, H | 3 |
| Bellina, RC | 2 |
| Di Marco, S | 1 |
| Nista, N | 2 |
| Riva, A | 1 |
| Camici, P | 1 |
| Italiani, G | 1 |
| Parodi, O | 1 |
| Ogata, M | 1 |
| Yabe, T | 1 |
| Yonesawa, Y | 1 |
| Takada, J | 1 |
| Odawara, H | 1 |
| Lucarini, AR | 1 |
| Lattanzi, F | 1 |
| De Prisco, F | 1 |
| Distante, A | 1 |
| Salvetti, A | 1 |
| Mori, T | 2 |
| Yamabe, H | 1 |
| Yokota, Y | 2 |
| Fukuzaki, H | 2 |
| Himi, T | 1 |
| Endo, M | 1 |
| Kagaya, A | 1 |
| Yoshida, K | 1 |
| Masuda, Y | 1 |
| Inagaki, Y | 1 |
| Fukuda, H | 1 |
| Fukuda, N | 1 |
| Iinuma, T | 1 |
| Yamazaki, T | 1 |
| Suda, K | 1 |
| Ohnishi, M | 1 |
| Kanoh, Y | 1 |
| Shiotani, H | 1 |
| Fujitani, K | 1 |
| Maeda, K | 1 |
| Shimamatsu, M | 1 |
| Pirelli, S | 1 |
| Inglese, E | 1 |
| Suppa, M | 1 |
| Corrada, E | 1 |
| Piccalò, G | 1 |
| Campolo, L | 1 |
| Carù, B | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The International Stress Echo Study to to Define the Future of Imaging[NCT05081115] | 10,000 participants (Anticipated) | Observational [Patient Registry] | 2021-04-01 | Recruiting | |||
| H215O Positron Emission Tomography (PET) in the Assessment of Synovial Blood Flow in Rheumatoid Arthritis Patients[NCT00014794] | Phase 1 | 10 participants | Interventional | 2001-04-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for dipyridamole and Cardiomyopathy, Hypertrophic Obstructive
| Article | Year |
|---|---|
Coronary flow reserve in patients with chest pain, angiographically normal coronary arteries and normal left ventricle, dilated cardiomyopathy, and hypertrophic cardiomyopathy.
Topics: Angina Pectoris; Cardiomyopathy, Dilated; Cardiomyopathy, Hypertrophic; Coronary Angiography; Corona | 1989 |
4 trials available for dipyridamole and Cardiomyopathy, Hypertrophic Obstructive
| Article | Year |
|---|---|
Effect of verapamil on absolute myocardial blood flow in hypertrophic cardiomyopathy.
Topics: Adult; Ammonia; Cardiomyopathy, Hypertrophic; Coronary Circulation; Dipyridamole; Double-Blind Metho | 1994 |
Improvement of coronary flow reserve after long-term therapy with enalapril.
Topics: Aged; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cardiomyopathy, Hyp | 1996 |
[Dipyridamole-echocardiography and thallium exercise myocardial scintigraphy in the diagnosis of obstructive coronary or microvascular disease in hypertensive patients with left ventricular hypertrophy and angina].
Topics: Adult; Aged; Angina Pectoris; Cardiomyopathy, Hypertrophic; Coronary Disease; Dipyridamole; Echocard | 1998 |
Transmural myocardial blood flow distribution in hypertrophic cardiomyopathy and effect of treatment.
Topics: Adult; Calcium Channel Blockers; Cardiomyopathy, Hypertrophic; Coronary Vessels; Dipyridamole; Femal | 1999 |
35 other studies available for dipyridamole and Cardiomyopathy, Hypertrophic Obstructive
| Article | Year |
|---|---|
Role of quantitative myocardial positron emission tomography for risk stratification in patients with hypertrophic cardiomyopathy: a 2016 reappraisal.
Topics: Adult; Cardiomyopathy, Hypertrophic; Causality; Comorbidity; Coronary Artery Disease; Dipyridamole; | 2016 |
Spatial relationship between coronary microvascular dysfunction and delayed contrast enhancement in patients with hypertrophic cardiomyopathy.
Topics: Adolescent; Adult; Aged; Ammonia; Cardiomyopathy, Hypertrophic; Contrast Media; Coronary Circulation | 2008 |
Prognostic implications of coronary flow reserve on left anterior descending coronary artery in hypertrophic cardiomyopathy.
Topics: Cardiomyopathy, Hypertrophic; Coronary Circulation; Coronary Vessels; Dipyridamole; Echocardiography | 2008 |
PET/CT assessment of symptomatic individuals with obstructive and nonobstructive hypertrophic cardiomyopathy.
Topics: Adult; Aged; Algorithms; Cardiomyopathy, Hypertrophic; Coronary Circulation; Data Interpretation, St | 2012 |
Comparison and effectiveness of regadenoson versus dipyridamole on stress electrocardiographic changes during positron emission tomography evaluation of patients with hypertrophic cardiomyopathy.
Topics: Adenosine A2 Receptor Antagonists; Cardiomyopathy, Hypertrophic; Coronary Circulation; Dipyridamole; | 2012 |
Assessing risk in hypertrophic cardiomyopathy.
Topics: Animals; Cardiomyopathy, Hypertrophic; Coronary Circulation; Dipyridamole; Humans; Prognosis; Risk F | 2003 |
Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy.
Topics: Adult; Analysis of Variance; Cardiomyopathy, Hypertrophic; Cohort Studies; Coronary Circulation; Dip | 2003 |
Dipyridamole echocardiography for diagnosis of coexistent coronary artery disease in hypertrophic cardiomyopathy. Echo-Persantine International Cooperative (EPIC) Study Group--Subproject Hypertrophic Cardiomyopathy.
Topics: Adult; Aged; Angina Pectoris; Arrhythmias, Cardiac; Cardiomyopathy, Hypertrophic; Coronary Angiograp | 1995 |
Evidence for a systemic defect of resistance-sized arterioles in hypertrophic cardiomyopathy.
Topics: Adult; Aged; Cardiac Volume; Cardiomyopathy, Hypertrophic; Coronary Circulation; Dipyridamole; Echoc | 1993 |
[Study of washout rate in patients with chronic renal failure by dipyridamole 201Tl myocardial scintigraphy--comparison with hypertrophic cardiomyopathy].
Topics: Cardiomyopathy, Hypertrophic; Coronary Disease; Dipyridamole; Female; Heart; Humans; Kidney Failure, | 1993 |
Regional thallium-201 washout and myocardial hypertrophy in hypertrophic cardiomyopathy and its relation to exertional chest pain.
Topics: Adolescent; Adult; Aged; Cardiomegaly; Cardiomyopathy, Hypertrophic; Chest Pain; Chi-Square Distribu | 1993 |
123I-labelled BMIPP fatty acid myocardial scintigraphy in patients with hypertropic cardiomyopathy: SPECT comparison with stress 201Tl.
Topics: Adult; Aged; Cardiomyopathy, Hypertrophic; Dipyridamole; Fatty Acids; Female; Heart; Humans; Iodine | 1993 |
Changes in coronary sinus pH during dipyridamole stress in patients with hypertrophic cardiomyopathy.
Topics: Adult; Cardiomyopathy, Hypertrophic; Coronary Circulation; Dipyridamole; Electrocardiography; Female | 1996 |
Coronary flow reserve and exercise capacity in hypertrophic cardiomyopathy.
Topics: Adult; Blood Flow Velocity; Cardiomyopathy, Hypertrophic; Coronary Circulation; Dipyridamole; Echoca | 1996 |
Coronary vasodilator reserve in primary and secondary left ventricular hypertrophy. A study with positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Cardiomyopathy, Hypertrophic; Coronary Circulation; Dipyridamole; Fe | 1997 |
Dipyridamole-induced ischemia as a prognostic marker of future adverse cardiac events in adult patients with hypertrophic cardiomyopathy. Echo Persantine Italian Cooperative (EPIC) Study Group, Subproject Hypertrophic Cardiomyopathy.
Topics: Adult; Aged; Cardiomyopathy, Hypertrophic; Dipyridamole; Echocardiography; Electrocardiography; Fema | 1997 |
Dipyridamole stress thallium-201 perfusion abnormalities in patients with hypertrophic cardiomyopathy. Relationship to clinical presentation and outcome.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cardiomyopathy, Hypertrophic; Child; Dipyridamole; Human | 1998 |
Effects of dipyridamole and adenine/ribose on ATP concentration and adenosine production in cardiac myocytes.
Topics: Adenine; Adenine Nucleotides; Adenosine; Adenosine Triphosphate; Cardiomyopathy, Dilated; Cardiomyop | 1998 |
Hypertrophic cardiomyopathy: MR measurement of coronary blood flow and vasodilator flow reserve in patients and healthy subjects.
Topics: Blood Flow Velocity; Cardiomyopathy, Hypertrophic; Case-Control Studies; Coronary Circulation; Dipyr | 1999 |
Significant regional heterogeneity of coronary flow reserve in paediatric hypertrophic cardiomyopathy.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Cardiomyopathy, Hypertrophic; Child; Corona | 2000 |
Stress-induced changes in subendocardial tissue texture in hypertrophic cardiomyopathy: an echocardiographic videodensitometric study.
Topics: Adult; Cardiomyopathy, Hypertrophic; Densitometry; Dipyridamole; Echocardiography, Stress; Endocardi | 2001 |
Septal stunning by dipyridamole stress shown on quantitative gated perfusion SPECT in a child with hypertrophic cardiomyopathy.
Topics: Cardiomyopathy, Hypertrophic; Child; Dipyridamole; Gated Blood-Pool Imaging; Heart Septum; Humans; M | 2002 |
Therapeutic effect of oral dipyridamole on myocardial perfusion and cardiac performance in patients with hypertrophic cardiomyopathy.
Topics: Administration, Oral; Cardiomyopathy, Hypertrophic; Coronary Circulation; Dipyridamole; Exercise Tes | 1992 |
[Regional myocardial perfusion and ischemia in hypertrophic cardiomyopathy].
Topics: Adult; Aged; Ammonia; Cardiomyopathy, Hypertrophic; Coronary Circulation; Coronary Disease; Dipyrida | 1991 |
Coronary vasodilation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy: a study with nitrogen-13 ammonia and positron emission tomography.
Topics: Ammonia; Cardiomyopathy, Hypertrophic; Coronary Circulation; Coronary Vessels; Dipyridamole; Female; | 1991 |
Decreased coronary vasodilatory capacity in hypertrophic cardiomyopathy determined by split-dose thallium-dipyridamole myocardial scintigraphy.
Topics: Adolescent; Adult; Aged; Cardiomyopathy, Hypertrophic; Coronary Angiography; Coronary Vessels; Dipyr | 1990 |
[Therapeutic effects of oral dipyridamole on myocardial perfusion and left ventricular function in patients with hypertrophic cardiomyopathy].
Topics: Administration, Oral; Adult; Cardiomyopathy, Hypertrophic; Coronary Circulation; Dipyridamole; Exerc | 1990 |
[Assessment of prognosis of patients with ventricular tachycardia: role of the underlying heart disease].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cardiac Catheterization; Cardiomyopathy, Dilated; Cardio | 1989 |
Dipyridamole-echocardiography test in essential hypertensives with chest pain and angiographically normal coronary arteries.
Topics: Angina Pectoris; Cardiomyopathy, Hypertrophic; Coronary Angiography; Coronary Disease; Dipyridamole; | 1989 |
Clinical significance of dipyridamole Tl-201 emission computed tomography perfusion abnormality for evaluating pathophysiological and pathological aspects in hypertrophic cardiomyopathy.
Topics: Adult; Aged; Cardiomyopathy, Hypertrophic; Coronary Circulation; Dipyridamole; Echocardiography; Fem | 1988 |
[Usefulness of positron emission tomography in the assessment of the effect of dipyridamole on regional myocardial blood flow].
Topics: Ammonia; Cardiomyopathy, Hypertrophic; Coronary Circulation; Dipyridamole; Humans; Myocardial Infarc | 1988 |
[Hypertrophic non-obstructive cardiomyopathy assessed by dipyridamole thallium single photon emission computed tomography: comparisons with hypertrophic cardiomyopathy with a dilated heart].
Topics: Adult; Aged; Cardiac Catheterization; Cardiomyopathy, Dilated; Cardiomyopathy, Hypertrophic; Dipyrid | 1987 |
[Decreased coronary reserve in patients with hypertrophic cardiomyopathy--a study using split dose thallium-201 dipyridamole myocardial imaging].
Topics: Adolescent; Adult; Cardiomyopathy, Hypertrophic; Coronary Circulation; Dipyridamole; Female; Heart; | 1987 |
Impaired coronary vasodilatory capacity after dipyridamole administration in hypertrophic cardiomyopathy.
Topics: Adolescent; Adult; Cardiac Catheterization; Cardiomyopathy, Hypertrophic; Coronary Circulation; Coro | 1987 |
[Assessment of coronary stenosis by myocardial scintigraphy with thallium-201 after dipyridamol infusion].
Topics: Adult; Aged; Angina Pectoris; Cardiomyopathy, Hypertrophic; Dipyridamole; Female; Heart; Humans; Mal | 1985 |